AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Evotec has sold its Just-Evotec Biologics site in Toulouse to Sandoz AG. Sandoz will take over 100% of Just-Evotec Biologics EU and receive an unlimited technology license for the site. The deal marks a significant development in the biologics market, with Sandoz set to leverage Evotec's expertise in biologics production.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet